Animal Pharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067319
  • December 2021
  • Pharmaceuticals
  • 125 Pages
Report Description

This report is a comprehensive study that examines the Animal Pharmaceuticals industry in depth. With reference to key regions and major nations, the study specifies the product type of Animal Pharmaceuticals as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Animal Pharmaceuticals market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Animal Pharmaceuticals market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Animal Pharmaceuticals market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Animal Pharmaceuticals Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Animal Pharmaceuticals market study. The market dynamics and factors such as the threat of a Animal Pharmaceuticals substitute, the threat of new entrants into the Animal Pharmaceuticals market, buyer bargaining power, supplier bargaining power to Animal Pharmaceuticals providing companies, and internal rivalry among Animal Pharmaceuticals providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Animal Pharmaceuticals market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Animal Pharmaceuticals industry.
 
Animal Pharmaceuticals Market Key Trends Analysis

The important factors influencing the growth of the Animal Pharmaceuticals market have been examined in this report. The driving factors that are boosting demand for Animal Pharmaceuticalss and the restraining factors that are slowing growth of the Animal Pharmaceuticals industry are addressed in depth, as well as their implications for the worldwide Animal Pharmaceuticals market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Animal Pharmaceuticals Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Animal Pharmaceuticals industry. On the basis of current and future trends, all segments of the Animal Pharmaceuticals industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Animal Pharmaceuticals Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Animal Pharmaceuticals market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Animal Pharmaceuticals market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Animal Pharmaceuticals market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Animal Pharmaceuticals market. All important stakeholders in the Animal Pharmaceuticals value chain and technological ecosystem are expected to benefit from the insights offered in the Animal Pharmaceuticals market research study.

In order to provide a broader understanding of the top competitors in the Animal Pharmaceuticals market, the research includes a company market share analysis. Aratana Therapeutics, Inc., Bayer AG, BioPredic International, Boehringer Ingelheim International GmbH, Ceva Animal Health LLC – Biomune, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Dechra Veterinary Products USA, Elanco Animal Health Inc., Eli Lilly & Company, Huvepharma, Inc., Liberty Pharma INC, Merck & Co. Inc., Perrigo Company plc, Sanofi, Sparhawk Laboratories, Vetoquinol S.A., Virbac SA, Zoetis Inc., Zoetis, Inc. are among the major participants in the global Animal Pharmaceuticals industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Aratana Therapeutics, Inc., Bayer AG, BioPredic International, Boehringer Ingelheim International GmbH, Ceva Animal Health LLC – Biomune, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Dechra Veterinary Products USA, Elanco Animal Health Inc., Eli Lilly & Company, Huvepharma, Inc., Liberty Pharma INC, Merck & Co. Inc., Perrigo Company plc, Sanofi, Sparhawk Laboratories, Vetoquinol S.A., Virbac SA, Zoetis Inc., Zoetis, Inc.
 
Major Highlights of the Animal Pharmaceuticals Market report study:
  • An in-depth examination of the global Animal Pharmaceuticals industry will be published soon.
  • The study examines the global Animal Pharmaceuticals market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Animal Pharmaceuticals industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Animal Pharmaceuticals market is being shaped by several major trends.
  • The size of the Animal Pharmaceuticals market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Animal Pharmaceuticals market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Animal Pharmaceuticals market as follows:
Global Animal Pharmaceuticals Market: By Product Type

  • Cats
  • Dogs
  • Horses

Global Animal Pharmaceuticals Market: By Application
  • Retail Pharmacies
  • Veterinary Clinics
  • Veterinary Hospitals

Global Animal Pharmaceuticals Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Animal Pharmaceuticals market.
  • Universities and students
  • Other companies in the Animal Pharmaceuticals market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Animal Pharmaceuticals market

Manufacturers and Segments

  • Aratana Therapeutics, Inc.
  • Bayer AG
  • BioPredic International
  • Boehringer Ingelheim International GmbH
  • Ceva Animal Health LLC – Biomune
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Dechra Veterinary Products USA
  • Elanco Animal Health Inc.
  • Eli Lilly & Company
  • Huvepharma, Inc.
  • Liberty Pharma INC
  • Merck & Co. Inc.
  • Perrigo Company plc
  • Sanofi
  • Sparhawk Laboratories
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis Inc.
  • Zoetis, Inc.
  • Cats
  • Dogs
  • Horses
  • Retail Pharmacies
  • Veterinary Clinics
  • Veterinary Hospitals

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Animal Pharmaceuticals Market Snapshot
          2.1.1. Global Animal Pharmaceuticals Market By Cats,2019
               2.1.1.1.
               2.1.1.2.Cats
               2.1.1.3.Dogs
          2.1.2. Global Animal Pharmaceuticals Market By Retail Pharmacies,2019
               2.1.2.1.
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Veterinary Clinics
          2.1.3. Global Animal Pharmaceuticals Market By End-use,2019
          2.1.4. Global Animal Pharmaceuticals Market By Geography,2019

3. Global Animal Pharmaceuticals Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Cats, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Cats, 2020
     4.2. Global Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028

5. Global Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Retail Pharmacies, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Retail Pharmacies, 2020
     5.2. Global Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028

6. Global Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

7. Global Animal Pharmaceuticals Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.2.1. North America Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.2.3. North America Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.2.4. North America Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.3.1.  Europe Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.3.3. Europe Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.3.4. Europe Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Animal Pharmaceuticals Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.4.3. Asia Pacific Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.4.4. Asia Pacific Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Animal Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.5.3. Latin America Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.5.4. Latin America Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Animal Pharmaceuticals Market Analysis, 2018 – 2028 
          7.6.1.  MEA Animal Pharmaceuticals Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Animal Pharmaceuticals Market Size (US$), By Cats, 2018 – 2028
          7.6.3. MEA Animal Pharmaceuticals Market Size (US$), By Retail Pharmacies, 2018 – 2028
          7.6.4. MEA Animal Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Animal Pharmaceuticals Providers
        8.4.1 Aratana Therapeutics, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Aratana Therapeutics, Inc. Geographic Operations
                8.4.1.3 Aratana Therapeutics, Inc. Financial Information
                8.4.1.4 Aratana Therapeutics, Inc. Product Positions/Portfolio
                8.4.1.5 Aratana Therapeutics, Inc. Key Developments
        8.4.2 Bayer AG
                8.4.2.1 Business Description
                8.4.2.2 Bayer AG Geographic Operations
                8.4.2.3 Bayer AG Financial Information
                8.4.2.4 Bayer AG Product Positions/Portfolio
                8.4.2.5 Bayer AG Key Developments
        8.4.3 BioPredic International
                8.4.3.1 Business Description
                8.4.3.2 BioPredic International Geographic Operations
                8.4.3.3 BioPredic International Financial Information
                8.4.3.4 BioPredic International Product Positions/Portfolio
                8.4.3.5 BioPredic International Key Developments
        8.4.4 Boehringer Ingelheim International GmbH
                8.4.4.1 Business Description
                8.4.4.2 Boehringer Ingelheim International GmbH Geographic Operations
                8.4.4.3 Boehringer Ingelheim International GmbH Financial Information
                8.4.4.4 Boehringer Ingelheim International GmbH Product Positions/Portfolio
                8.4.4.5 Boehringer Ingelheim International GmbH Key Developments
        8.4.5 Ceva Animal Health LLC – Biomune
                8.4.5.1 Business Description
                8.4.5.2 Ceva Animal Health LLC – Biomune Geographic Operations
                8.4.5.3 Ceva Animal Health LLC – Biomune Financial Information
                8.4.5.4 Ceva Animal Health LLC – Biomune Product Positions/Portfolio
                8.4.5.5 Ceva Animal Health LLC – Biomune Key Developments
        8.4.6 Ceva Sante Animale
                8.4.6.1 Business Description
                8.4.6.2 Ceva Sante Animale Geographic Operations
                8.4.6.3 Ceva Sante Animale Financial Information
                8.4.6.4 Ceva Sante Animale Product Positions/Portfolio
                8.4.6.5 Ceva Sante Animale Key Developments
        8.4.7 Dechra Pharmaceuticals PLC
                8.4.7.1 Business Description
                8.4.7.2 Dechra Pharmaceuticals PLC Geographic Operations
                8.4.7.3 Dechra Pharmaceuticals PLC Financial Information
                8.4.7.4 Dechra Pharmaceuticals PLC Product Positions/Portfolio
                8.4.7.5 Dechra Pharmaceuticals PLC Key Developments
        8.4.8 Dechra Veterinary Products USA
                8.4.8.1 Business Description
                8.4.8.2 Dechra Veterinary Products USA Geographic Operations
                8.4.8.3 Dechra Veterinary Products USA Financial Information
                8.4.8.4 Dechra Veterinary Products USA Product Positions/Portfolio
                8.4.8.5 Dechra Veterinary Products USA Key Developments
        8.4.9 Elanco Animal Health Inc.
                8.4.9.1 Business Description
                8.4.9.2 Elanco Animal Health Inc. Geographic Operations
                8.4.9.3 Elanco Animal Health Inc. Financial Information
                8.4.9.4 Elanco Animal Health Inc. Product Positions/Portfolio
                8.4.9.5 Elanco Animal Health Inc. Key Developments
        8.4.10 Eli Lilly & Company
                8.4.10.1 Business Description
                8.4.10.2 Eli Lilly & Company Geographic Operations
                8.4.10.3 Eli Lilly & Company Financial Information
                8.4.10.4 Eli Lilly & Company Product Positions/Portfolio
                8.4.10.5 Eli Lilly & Company Key Developments
        8.4.11 Huvepharma, Inc.
                8.4.11.1 Business Description
                8.4.11.2 Huvepharma, Inc. Geographic Operations
                8.4.11.3 Huvepharma, Inc. Financial Information
                8.4.11.4 Huvepharma, Inc. Product Positions/Portfolio
                8.4.11.5 Huvepharma, Inc. Key Developments
        8.4.12 Liberty Pharma INC
                8.4.12.1 Business Description
                8.4.12.2 Liberty Pharma INC Geographic Operations
                8.4.12.3 Liberty Pharma INC Financial Information
                8.4.12.4 Liberty Pharma INC Product Positions/Portfolio
                8.4.12.5 Liberty Pharma INC Key Developments
        8.4.13 Merck & Co. Inc.
                8.4.13.1 Business Description
                8.4.13.2 Merck & Co. Inc. Geographic Operations
                8.4.13.3 Merck & Co. Inc. Financial Information
                8.4.13.4 Merck & Co. Inc. Product Positions/Portfolio
                8.4.13.5 Merck & Co. Inc. Key Developments
        8.4.14 Perrigo Company plc
                8.4.14.1 Business Description
                8.4.14.2 Perrigo Company plc Geographic Operations
                8.4.14.3 Perrigo Company plc Financial Information
                8.4.14.4 Perrigo Company plc Product Positions/Portfolio
                8.4.14.5 Perrigo Company plc Key Developments
        8.4.15 Sanofi
                8.4.15.1 Business Description
                8.4.15.2 Sanofi Geographic Operations
                8.4.15.3 Sanofi Financial Information
                8.4.15.4 Sanofi Product Positions/Portfolio
                8.4.15.5 Sanofi Key Developments
        8.4.16 Sparhawk Laboratories
                8.4.16.1 Business Description
                8.4.16.2 Sparhawk Laboratories Geographic Operations
                8.4.16.3 Sparhawk Laboratories Financial Information
                8.4.16.4 Sparhawk Laboratories Product Positions/Portfolio
                8.4.16.5 Sparhawk Laboratories Key Developments
        8.4.17 Vetoquinol S.A.
                8.4.17.1 Business Description
                8.4.17.2 Vetoquinol S.A. Geographic Operations
                8.4.17.3 Vetoquinol S.A. Financial Information
                8.4.17.4 Vetoquinol S.A. Product Positions/Portfolio
                8.4.17.5 Vetoquinol S.A. Key Developments
        8.4.18 Virbac SA
                8.4.18.1 Business Description
                8.4.18.2 Virbac SA Geographic Operations
                8.4.18.3 Virbac SA Financial Information
                8.4.18.4 Virbac SA Product Positions/Portfolio
                8.4.18.5 Virbac SA Key Developments
        8.4.19 Zoetis Inc.
                8.4.19.1 Business Description
                8.4.19.2 Zoetis Inc. Geographic Operations
                8.4.19.3 Zoetis Inc. Financial Information
                8.4.19.4 Zoetis Inc. Product Positions/Portfolio
                8.4.19.5 Zoetis Inc. Key Developments
        8.4.20 Zoetis, Inc.
                8.4.20.1 Business Description
                8.4.20.2 Zoetis, Inc. Geographic Operations
                8.4.20.3 Zoetis, Inc. Financial Information
                8.4.20.4 Zoetis, Inc. Product Positions/Portfolio
                8.4.20.5 Zoetis, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Animal Pharmaceuticals Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Animal Pharmaceuticals Market Revenue, By Cats, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Animal Pharmaceuticals Market Revenue, By Retail Pharmacies, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Animal Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Animal Pharmaceuticals: Market Segmentation 
FIG. 2 Global Animal Pharmaceuticals Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Animal Pharmaceuticals Market, By Cats, 2019 (US$ Mn) 
FIG. 5 Global Animal Pharmaceuticals Market, By Retail Pharmacies, 2019 (US$ Mn) 
FIG. 6 Global Animal Pharmaceuticals Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Animal Pharmaceuticals Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Animal Pharmaceuticals Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Animal Pharmaceuticals Providers, 2019
FIG. 11 Global Animal Pharmaceuticals Market Revenue Contribution, By Cats, 2019 & 2028 (Value %) 
FIG. 12 Global Animal Pharmaceuticals Market Revenue Contribution, By Retail Pharmacies, 2019 & 2028 (Value %) 
FIG. 13 Global Animal Pharmaceuticals Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Animal Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Animal Pharmaceuticals market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Animal Pharmaceuticals Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  North America Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  North America Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Europe Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Europe Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Europe Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Latin America Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  MEA Animal Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  MEA Animal Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  MEA Animal Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Aratana Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioPredic International: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva Animal Health LLC – Biomune: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva Sante Animale: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dechra Pharmaceuticals PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dechra Veterinary Products USA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elanco Animal Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly & Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Huvepharma, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Liberty Pharma INC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co. Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Perrigo Company plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sparhawk Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vetoquinol S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Virbac SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zoetis Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zoetis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Animal Pharmaceuticals Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Animal Pharmaceuticals Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Animal Pharmaceuticals Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Animal Pharmaceuticals Market, By Geography, 2019 (US$ Mn)
FIG.  Global Animal Pharmaceuticals Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Animal Pharmaceuticals Providers, 2016
FIG.  Global Animal Pharmaceuticals Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cats Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Dogs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Horses Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Animal Pharmaceuticals Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Veterinary Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Veterinary Hospitals Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Animal Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)